PHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2020
| PHARMANIAGA BERHAD |
| Financial Year End | 31 Dec 2020 |
| Quarter | 3 Qtr |
| Quarterly report for the financial period ended | 30 Sep 2020 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Sep 2020
|
30 Sep 2019
|
30 Sep 2020
|
30 Sep 2019
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
624,804
|
716,849
|
2,090,488
|
2,104,847
|
| 2 | Profit/(loss) before tax |
4,093
|
3,885
|
49,299
|
46,609
|
| 3 | Profit/(loss) for the period |
1,294
|
376
|
33,316
|
29,286
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
1,442
|
481
|
33,820
|
29,379
|
| 5 | Basic earnings/(loss) per share (Subunit) |
0.55
|
0.18
|
12.94
|
11.26
|
| 6 | Proposed/Declared dividend per share (Subunit) |
1.50
|
0.00
|
10.00
|
8.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
1.3200
|
1.2900
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 19 Nov 2020 |
| Category | Financial Results |
| Reference Number | FRA-18112020-00011 |